Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use
NCT02695706 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2016-03-03
Summary
The measured product in this research is a product for topical use, Laboratoires Mercurochrome Reparador e Protetor. The expected benefit to the use of the product is the improvement in skin hydration as measured by self perception of participant research and clinical evaluation and improvement in local microcirculation, assessed by instrumental measurements in feet of the study participants.
Conditions
Interventions
- DEVICE
-
Laboratoires Mercurochrome Reparador
Developed for the treatment of damaged or fragile skin.
Sponsors & Collaborators
-
LM Farma Indústria e Comércio Ltda.
lead INDUSTRY
Principal Investigators
-
Alexandre Tepas, Graduated · Urgo
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2016-04-30
- Completion
- 2016-07-31
More Related Trials
-
Efficacy of ProgenaMatrix™ in the Management of DFUs
NCT06292026 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water
NCT02097615 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer
NCT03700580 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
NCT06826339 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
NCT05930210 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
NCT01396837 ·Status: COMPLETED ·Phase: PHASE2
-
Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds
NCT04709419 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
NCT00796744 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Diabetic Foot Ulcers Through Cleaner Feet
NCT03503370 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of the Use of Low Intensity Therapeutic LASER
NCT05530486 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
NCT06562296 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Low-level Laser Therapy in the Treatment of Diabetic Foot Ulcers
NCT04246814 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial To Study The Anti-scarring Effect Of Cicatricell
NCT03020420 ·Status: COMPLETED ·Phase: NA
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
NCT03626623 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers
NCT00235196 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
NCT02866565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Topic Insulin Accelerates Wound Healing in Diabetes
NCT01295177 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot
NCT03209466 ·Status: UNKNOWN ·Phase: PHASE4
-
The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing
NCT06584617 ·Status: RECRUITING ·Phase: NA
-
Comparing the Efficacy of the ConvaTec Engenex® Negative Pressure Wound Therapy Device to Moist Wound Therapy
NCT01108276 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
NCT04564443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
NCT06810726 ·Status: RECRUITING ·Phase: PHASE2
-
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT06403605 ·Status: COMPLETED ·Phase: NA
-
The Short Message-based Customized Standardized
NCT06037369 ·Status: TERMINATED ·Phase: NA